合理使用有毒中藥是保障中藥安全的關(guān)鍵，配伍是中藥減毒有效措施之一。通過對當(dāng)前中藥配伍減毒的評價模型、減毒方法、減毒技術(shù)及減毒機(jī)制進(jìn)行梳理，同時針對目前中藥配伍減毒存在的西醫(yī)模式化研究思路的既定困局及如何在中醫(yī)藥理論指導(dǎo)下開展有毒中藥配伍減毒的現(xiàn)代化研究提出了客觀建議，為有毒中藥配伍減毒研究體系的進(jìn)一步完善規(guī)避用藥風(fēng)險和指導(dǎo)安全用藥提供保障。

The prudent use of potentially toxic traditional Chinese medicine (TCM) is essential for ensuring its safety, with compatibility serving as a critical strategy for mitigating toxicity. This article presented a comprehensive review of the evaluation models, methodologies, techniques, and mechanisms associated with TCM compatibility for toxicity reduction. Additionally, it provided objective recommendations for conducting modern research on TCM compatibility within the framework of TCM theory. The goal is to enhance the research system focused on TCM compatibility for toxicity reduction, minimize medication-related risks and promote safe medication practices.

R28

國家自然科學(xué)基金資助項(xiàng)目（82204938）;國家自然科學(xué)基金資助項(xiàng)目（82404774）;國家自然科學(xué)基金資助項(xiàng)目（82404736）;河南省醫(yī)學(xué)科技攻關(guān)計(jì)劃項(xiàng)目（LHGJ20240427）;湖北省教育廳重點(diǎn)項(xiàng)目（D20232101）;襄陽市第一人民醫(yī)院科研創(chuàng)新項(xiàng)目（XYY2023ZY01）;湖北醫(yī)藥學(xué)院附屬襄陽市第一人民醫(yī)院博士科研啟動金（XYY2023D05）